Literature DB >> 25839986

Quality and length of life, money and urethral stricture disease.

Matthew J Jackson1, Stella L Ivaz.   

Abstract

PURPOSE OF REVIEW: This article walks through some of the ideas behind patient-reported outcome measurement and quality of life research against the backdrop of urethral stricture disease and conditions of the lower urinary tract more generally, why measurement matters at all, future areas for research and development and potential opportunities for misuse and manipulation. RECENT
FINDINGS: It is the authors' opinion that only one published study has substantially advanced our understanding of the way men with urethral stricture disease manage this condition in the real world, and, in turn, the outcomes those men seek when they consent to surgery and its associated risks. There is, however, almost certainly greater acceptance now by reconstructive urologists of the utility of patient-reported outcome measures in audit; surgical performance evaluation; clinical research; and fair, logical and transparent healthcare resource allocation at a population level. This is evidenced by the recent proliferation of studies incorporating patient-reported outcomes, which appear today to be on parity at least with those that surgeons historically gave priority to.
SUMMARY: The next frontier in urethral stricture disease outcomes research is a better understanding of the impact of this condition on men's daily lives. That level of insight is likely to be gained through a mixture of qualitative and quantitative research methods applied to collaborative research ventures with men with the condition who, as those that have the most to gain and lose, must be majority stakeholders in this process.

Entities:  

Mesh:

Year:  2015        PMID: 25839986     DOI: 10.1097/MOU.0000000000000179

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  3 in total

1.  The International Prostate Symptom Score (IPSS) Is an Inadequate Tool to Screen for Urethral Stricture Recurrence After Anterior Urethroplasty.

Authors:  Christopher A Tam; Sean P Elliott; Bryan B Voelzke; Jeremy B Myers; Alex J Vanni; Benjamin N Breyer; Thomas G Smith; Christopher D McClung; Bradley A Erickson
Journal:  Urology       Date:  2016-04-21       Impact factor: 2.649

2.  Fasudil inhibits proliferation and collagen synthesis and induces apoptosis of human fibroblasts derived from urethral scar via the Rho/ROCK signaling pathway.

Authors:  Ning Xu; Shao-Hao Chen; Gen-Yi Qu; Xiao-Dong Li; Wen Lin; Xue-Yi Xue; Yun-Zhi Lin; Qing-Shui Zheng; Yong Wei
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

3.  Anterior Urethral Stricture Disease Negatively Impacts the Quality of Life of Family Members.

Authors:  Jonathan R Weese; Valary T Raup; Jairam R Eswara; Stephen D Marshall; Andrew J Chang; Joel Vetter; Steven B Brandes
Journal:  Adv Urol       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.